⌘K

17:00:01·846d

SECFilingvia Quantisnow

Werewolf Therapeutics Inc. filed SEC Form 8-K: Leadership Update

ByQuantisnow·Wall Street's wire, on your screen.

HOWL· Werewolf Therapeutics Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

HOWL
Werewolf Therapeutics Inc.
Health Care

Recent analyst ratings

Dec 19UpdateWedbush$1.00
Apr 3UpdateJMP Securities$12.00
Aug 24UpdateWedbush$9.00
Jun 6UpdateJefferies$12.00
Nov 19UpdateSVB Leerink$28.00
Sep 10UpdateBofA Securities$26.00

Related

INSIDER17h
Director Evnin Luke sold $154,525 worth of shares (205,911 units at $0.75) as part of a pre-agreed trading plan (SEC Form 4)
SEC20h
SEC Form 144 filed by Werewolf Therapeutics Inc.
SEC20h
SEC Form 144 filed by Werewolf Therapeutics Inc.
SEC20h
SEC Form 144 filed by Werewolf Therapeutics Inc.
SEC20h
SEC Form 144 filed by Werewolf Therapeutics Inc.
SEC20h
SEC Form 144 filed by Werewolf Therapeutics Inc.
SEC20h
SEC Form 144 filed by Werewolf Therapeutics Inc.
SEC2d
SEC Form 144 filed by Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc. filed SEC Form 8-K: Leadership Update | Quantisnow